CAGGIANO, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 2.611
AS - Asia 2.232
NA - Nord America 1.984
SA - Sud America 337
AF - Africa 127
OC - Oceania 3
Totale 7.294
Nazione #
US - Stati Uniti d'America 1.897
IT - Italia 1.226
RU - Federazione Russa 703
SG - Singapore 672
CN - Cina 549
VN - Vietnam 317
BR - Brasile 257
BD - Bangladesh 189
HK - Hong Kong 151
KR - Corea 147
IE - Irlanda 122
DE - Germania 116
GB - Regno Unito 90
FR - Francia 86
FI - Finlandia 71
NL - Olanda 71
IN - India 67
ZA - Sudafrica 61
CA - Canada 46
MX - Messico 30
AR - Argentina 27
TR - Turchia 21
SE - Svezia 20
IQ - Iraq 17
JP - Giappone 17
PL - Polonia 15
AT - Austria 14
CI - Costa d'Avorio 14
KE - Kenya 14
VE - Venezuela 14
CZ - Repubblica Ceca 13
ES - Italia 12
MA - Marocco 12
SA - Arabia Saudita 12
UZ - Uzbekistan 10
EC - Ecuador 9
CL - Cile 8
ID - Indonesia 8
PK - Pakistan 8
CO - Colombia 7
PE - Perù 7
TN - Tunisia 7
CH - Svizzera 6
DZ - Algeria 6
EG - Egitto 6
LT - Lituania 6
PH - Filippine 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
PY - Paraguay 5
AL - Albania 4
CR - Costa Rica 4
IR - Iran 4
JO - Giordania 4
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
JM - Giamaica 3
LB - Libano 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
IL - Israele 2
KZ - Kazakistan 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
TM - Turkmenistan 2
AM - Armenia 1
CG - Congo 1
CM - Camerun 1
GI - Gibilterra 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.293
Città #
Dallas 509
Singapore 402
Hefei 247
Moscow 210
San Jose 195
Milan 188
Santa Clara 164
Seoul 147
Hong Kong 143
Ashburn 139
Dublin 118
Ho Chi Minh City 109
Rome 96
New York 88
Beijing 86
Los Angeles 81
Hanoi 72
Council Bluffs 65
Siena 59
Johannesburg 58
Lauterbourg 56
Florence 49
Munich 45
The Dalles 43
Helsinki 33
Orem 33
Chicago 31
Bengaluru 29
Buffalo 28
São Paulo 27
Lappeenranta 26
Da Nang 24
Southend 24
Turin 23
Redondo Beach 22
Naples 21
Bologna 20
Frankfurt am Main 20
Bari 19
London 17
Nuremberg 17
Chennai 16
Haiphong 15
Abidjan 14
Perugia 14
Tokyo 14
Warsaw 14
Amsterdam 13
Mexico City 13
Montreal 13
Düsseldorf 12
Houston 12
Lucca 12
Padova 12
Portsmouth 12
Turku 12
Livorno 11
Manchester 11
Messina 11
Reggio Emilia 11
Toronto 11
Verona 11
Monza 10
Atlanta 9
Denver 9
Fairfield 9
Istanbul 9
Palermo 9
Seattle 9
Sutri 9
Tashkent 9
Bergamo 8
Brescia 8
Olomouc 8
San Francisco 8
Stockholm 8
Wilmington 8
Baghdad 7
Biên Hòa 7
Brooklyn 7
Charlotte 7
Curitiba 7
Genoa 7
Hải Dương 7
Pisa 7
Venice 7
Catania 6
Guangzhou 6
Modena 6
Mumbai 6
Parma 6
Ravenna 6
Salerno 6
Vienna 6
Acerra 5
Ankara 5
Biella 5
Boston 5
Brindisi 5
Cascina 5
Totale 4.318
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 888
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 223
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 219
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 213
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 211
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 204
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 195
Development and implementation of the AIDA International Registry for patients with Behçet's disease 194
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry 188
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 178
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 172
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 169
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 167
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 167
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 164
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 152
Comparing biologic options for the management of Behcet's disease-related uveitis 149
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 148
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 143
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe 140
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 140
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 139
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 137
Development and implementation of the AIDA international registry for patients with Still's disease 136
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 134
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 134
Development and implementation of the international AIDA network spondylarthritis registry 133
Efficacy and safety of adalimumab in pediatric non-infectious non-anterior uveitis: real-life experience from the International AIDA Network Uveitis Registry 132
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 130
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 123
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 122
The role of biologic agents in the management of pediatric-onset noninfectious posterior scleritis 121
The current status of biological treatment for uveitis 121
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries 117
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 107
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: a multicenter study from the AIDA Network PFAPA syndrome registry 106
Development and implementation of the International AIDA Network Castleman’s disease registry 104
Imaging findings in patients with axial spondyloarthritis presenting with recurrent fever attacks: data from the international AIDA network spondyloarthritis registry 102
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 100
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry 97
The autoinflammatory diseases alliance registry of monogenic autoinflammatory diseases 93
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry 91
Systemic auto-inflammatory manifestations in patients with spondyloarthritis 82
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry 81
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry 81
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 73
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry 60
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry 58
Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry 46
Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry 36
VEXAS syndrome and cancer: Insights about a possible “Tip of the Iceberg”. Ambidirectional data from the international AIDA network registries 32
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries 22
Totale 7.474
Categoria #
all - tutte 19.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/202236 2 6 3 2 2 0 1 5 3 1 5 6
2022/2023109 2 3 6 3 0 3 2 1 44 5 26 14
2023/2024566 9 16 40 39 55 90 111 54 14 36 49 53
2024/20251.902 139 73 189 116 181 126 84 139 157 97 156 445
2025/20264.786 324 595 488 589 725 161 601 178 221 321 319 264
Totale 7.474